The activity of propolis against pathogenic fungi isolated from human infections
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/210969 |
Resumo: | Propolis is a resinous hive product collected by bees from the buds or other parts of plants. It is known for having various biological properties, including antifungal activity. Among the substances present in propolis, flavonoids and phenolic acids and their esters are responsible for its antifungal properties. This means that propolis is ideal for use as an antifungal agent in alternative medicine to treat a number of both topical and systemic infections caused by Candida species and other yeast-like fungi, dermatophyte and nondermatophyte moulds, without the serious side effects typical of synthetic treatment. It is also active against strains of fungi that are resistant to polyenes and azoles, the classes of drugs most commonly used to treat fungal infections. In this article, we review current knowledge about the activity of propolis from different parts of the world and its components in vitro and in vivo against pathogenic fungi isolated from human infections. The article also indicates the possible mechanism of antifungal activity of propolis and its components. |
id |
USP-31_d431d1e84f3f7611045242365a24e809 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/210969 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
The activity of propolis against pathogenic fungi isolated from human infectionsPropolis; Antifungal activity; Human infectionsPropolis is a resinous hive product collected by bees from the buds or other parts of plants. It is known for having various biological properties, including antifungal activity. Among the substances present in propolis, flavonoids and phenolic acids and their esters are responsible for its antifungal properties. This means that propolis is ideal for use as an antifungal agent in alternative medicine to treat a number of both topical and systemic infections caused by Candida species and other yeast-like fungi, dermatophyte and nondermatophyte moulds, without the serious side effects typical of synthetic treatment. It is also active against strains of fungi that are resistant to polyenes and azoles, the classes of drugs most commonly used to treat fungal infections. In this article, we review current knowledge about the activity of propolis from different parts of the world and its components in vitro and in vivo against pathogenic fungi isolated from human infections. The article also indicates the possible mechanism of antifungal activity of propolis and its components.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-04-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21096910.1590/s2175-97902023e19978Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e19978Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e19978Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e199782175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/210969/194613https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessKatarzyna WolskaKatarzyna Antosik2023-05-31T18:08:21Zoai:revistas.usp.br:article/210969Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-05-31T18:08:21Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
The activity of propolis against pathogenic fungi isolated from human infections |
title |
The activity of propolis against pathogenic fungi isolated from human infections |
spellingShingle |
The activity of propolis against pathogenic fungi isolated from human infections Katarzyna Wolska Propolis; Antifungal activity; Human infections |
title_short |
The activity of propolis against pathogenic fungi isolated from human infections |
title_full |
The activity of propolis against pathogenic fungi isolated from human infections |
title_fullStr |
The activity of propolis against pathogenic fungi isolated from human infections |
title_full_unstemmed |
The activity of propolis against pathogenic fungi isolated from human infections |
title_sort |
The activity of propolis against pathogenic fungi isolated from human infections |
author |
Katarzyna Wolska |
author_facet |
Katarzyna Wolska Katarzyna Antosik |
author_role |
author |
author2 |
Katarzyna Antosik |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Katarzyna Wolska Katarzyna Antosik |
dc.subject.por.fl_str_mv |
Propolis; Antifungal activity; Human infections |
topic |
Propolis; Antifungal activity; Human infections |
description |
Propolis is a resinous hive product collected by bees from the buds or other parts of plants. It is known for having various biological properties, including antifungal activity. Among the substances present in propolis, flavonoids and phenolic acids and their esters are responsible for its antifungal properties. This means that propolis is ideal for use as an antifungal agent in alternative medicine to treat a number of both topical and systemic infections caused by Candida species and other yeast-like fungi, dermatophyte and nondermatophyte moulds, without the serious side effects typical of synthetic treatment. It is also active against strains of fungi that are resistant to polyenes and azoles, the classes of drugs most commonly used to treat fungal infections. In this article, we review current knowledge about the activity of propolis from different parts of the world and its components in vitro and in vivo against pathogenic fungi isolated from human infections. The article also indicates the possible mechanism of antifungal activity of propolis and its components. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-04-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/210969 10.1590/s2175-97902023e19978 |
url |
https://www.revistas.usp.br/bjps/article/view/210969 |
identifier_str_mv |
10.1590/s2175-97902023e19978 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/210969/194613 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e19978 Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e19978 Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e19978 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222917668110336 |